Sergey Deyev Selected Research

Tyrosine Kinase Inhibitors

1/2018

Comparative Evaluation of Radioiodine and Technetium-Labeled DARPin 9_29 for Radionuclide Molecular Imaging of HER2 Expression in Malignant Tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sergey Deyev Research Topics

Disease

23	Neoplasms (Cancer) 04/2024 - 10/2015
7	Breast Neoplasms (Breast Cancer) 03/2024 - 10/2016
3	Ovarian Neoplasms (Ovarian Cancer) 11/2022 - 05/2019
3	Carcinoma (Carcinomatosis) 05/2020 - 10/2015
2	Adenocarcinoma 09/2019 - 05/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024
1	B-Cell Leukemia (Leukemia, B Cell) 11/2021
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Triple Negative Breast Neoplasms 10/2020
1	Lymphoma (Lymphomas) 05/2020
1	Disease Progression 06/2019
1	Multiple Sclerosis 07/2016

Drug/Important Bio-Agent (IBA)

16	Designed Ankyrin Repeat ProteinsIBA 04/2024 - 10/2016
6	Proteins (Proteins, Gene)FDA Link 06/2023 - 09/2018
5	Radioisotopes (Radionuclides)IBA 11/2022 - 01/2018
4	Liposomes (Liposome)IBA 09/2022 - 09/2018
4	human ERBB2 proteinIBA 09/2022 - 01/2018
4	Immunotoxins (Immunotoxin)IBA 01/2020 - 10/2015
3	ErbB Receptors (EGF Receptor)IBA 11/2022 - 10/2017
3	Epithelial Cell Adhesion MoleculeIBA 10/2020 - 05/2020
2	Chelating AgentsIBA 04/2024 - 11/2022
2	Lapatinib (GW572016)FDA Link 03/2024 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 12/2022 - 01/2018
2	Bacillus amyloliquefaciens ribonucleaseIBA 11/2021 - 10/2020
2	GoldIBA 09/2019 - 10/2017
1	Amino Acids FDA Link 04/2024
1	glycyl-glycyl-glycine (triglycine)IBA 04/2024
1	glutamyl-glutamic acid (Glu-Glu)IBA 04/2024
1	Peptides (Polypeptides)IBA 11/2022
1	Peptide Nucleic AcidsIBA 09/2022
1	Bacillus amyloliquefaciens barstar protein (barstar)IBA 11/2021
1	Drug CarriersIBA 05/2021
1	PolymersIBA 05/2021
1	AntigensIBA 10/2020
1	GD2 gangliosideIBA 05/2020
1	EnzymesIBA 05/2020
1	GangliosidesIBA 05/2020
1	RNA (Ribonucleic Acid)IBA 05/2020
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	PolyethyleneimineIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2019
1	Antineoplastic Agents (Antineoplastics)IBA 05/2019
1	Epidermal Growth Factor (EGF)IBA 01/2019
1	pertuzumabIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	Technetium (Technetium 99m)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Ado-Trastuzumab EmtansineIBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	Pseudomonas aeruginosa Exotoxin AIBA 10/2016
1	Cytotoxins (Cytolysins)IBA 10/2016
1	Myelin-Oligodendrocyte GlycoproteinIBA 07/2016
1	AutoantigensIBA 07/2016
1	ExotoxinsIBA 10/2015

Therapy/Procedure

17	Therapeutics 04/2024 - 10/2017
1	Immunotherapy 05/2020
1	Injections 01/2020
1	Phototherapy (Light Therapy) 09/2019
1	Drug Therapy (Chemotherapy) 05/2019
1	Intravenous Administration 10/2016